Morgan Stanley’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.9M Buy
319,954
+158,843
+99% +$8.38M ﹤0.01% 3242
2026
Q1
$8.49M Buy
161,111
+87,028
+117% +$4.59M ﹤0.01% 3702
2025
Q4
$3.91M Buy
74,083
+73,625
+16,075% +$3.9M ﹤0.01% 4366
2025
Q3
$24.3K Sell
458
-1
-0.2% -$53 ﹤0.01% 6624
2025
Q2
$24.3K Buy
459
+259
+130% +$13.6K ﹤0.01% 6588
2025
Q1
$10.6K Sell
200
-1,467
-88% -$77.7K ﹤0.01% 6782
2024
Q4
$88K Sell
1,667
-491
-23% -$26K ﹤0.01% 6105
2024
Q3
$114K Buy
2,158
+2,130
+7,607% +$113K ﹤0.01% 5951
2024
Q2
$1.5K Buy
28
+27
+2,700% +$1.43K ﹤0.01% 7103
2024
Q1
$65 Buy
+1
New +$52 ﹤0.01% 7429

Other funds holding CLOI

Morgan Stanley's CLOI Position: Q2 2026 in Review

Morgan Stanley increased its VanEck CLO ETF (CLOI) stake by 99% in Q2 2026, buying an estimated $8.38M and bringing the position to 319,954 shares worth $16.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3242.

Morgan Stanley first reported a position in CLOI in Q1 2024 and has held it in 10 quarters since. 198 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

  • Morgan Stanley held 319,954 shares of VanEck CLO ETF worth $16.9M as of Q2 2026.
  • Morgan Stanley bought 158,843 VanEck CLO ETF shares in Q2 2026, an estimated $8.38M.
  • VanEck CLO ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3242 holding.
  • Morgan Stanley first reported a position in VanEck CLO ETF in Q1 2024 and has held it in 10 quarters since.
  • 198 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.